Marshall Wace
TRVI icon

Marshall Wace’s Trevi Therapeutics TRVI Stock Holding History

Marshall Wace’s Portfolio TRVI Stock Details TRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$47.3M Sell
3,966,019
-614,529
-13% -$6.88M 0.05% 382
2025
Q4 		$57.3M Sell
4,580,548
-261,203
-5% -$3.02M 0.06% 315
2025
Q3 		$44.3M Buy
4,841,751
+2,363,835
+95% +$17.7M 0.05% 357
2025
Q2 		$13.6M Sell
2,477,916
-76,305
-3% -$475K 0.02% 726
2025
Q1 		$16.1M Buy
2,554,221
+2,511,300
+5,851% +$12M 0.02% 583
2024
Q4 		$177K Sell
42,921
-38,203
-47% -$122K ﹤0.01% 2369
2024
Q3 		$271K Buy
+81,124
New +$241K ﹤0.01% 2192
2022
Q4 		– Sell
-128,324
Closed -$198K – 3518
2022
Q3 		$198K Buy
+128,324
New +$421K ﹤0.01% 3086
2022
Q2 		– Sell
-23,402
Closed -$52K – 3943
2022
Q1 		$52K Buy
+23,402
New +$24.2K ﹤0.01% 3244

Other funds holding TRVI

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return